Leucine-rich repeat kinase 2 and Parkinson's disease-Reference-Cited by-同舟云学术

Leucine-rich repeat kinase 2 and Parkinson's disease

Published:2016-12-21 Issue:1-2 Volume:17 Page:1600092
ISSN:1615-9853
Container-title:PROTEOMICS
language:en
Short-container-title:Proteomics

Author:

Kang Un-Beom¹,Marto Jarrod A.¹

Affiliation:

1. Department of Cancer Biology and Blais Proteomics Center; Dana-Farber Cancer Institute; Department of Biological Chemistry and Molecular Pharmacology; Harvard Medical School; Boston MA USA

Funder

Michael J. Fox Foundation LEAPS Research Program

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pmic.201600092/fullpdf

Reference111 articles.

1. Parkinson's disease: mechanisms and models;Dauer;Neuron,2003

2. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity;Den Eeden;Am. J. Epidemiol.,2003

3. Staging of brain pathology related to sporadic Parkinson's disease;Braak;Neurobiol. Aging,2003

4. Spontaneous dyskinesia and parkinsonism in never-medicated, chronically ill patients with schizophrenia: 18-month follow-up;McCreadie;Br. J. Psychiatry,2002

5. Leucine-rich repeat kinase 2 (LRRK2) cellular biology: a review of recent advances in identifying physiological substrates and cellular functions;Drolet;J. Neurogenet.,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of LRRK2 Attenuates Depression-Related Symptoms in Mice with Moderate Traumatic Brain Injury;Cells;2023-03-29

2. Bone Marrow Stem Cell-Exo-Derived TSG-6 Attenuates 1-Methyl-4-Phenylpyridinium+-Induced Neurotoxicity via the STAT3/miR-7/NEDD4/LRRK2 Axis;Journal of Neuropathology & Experimental Neurology;2022-06-30

3. Protecting Effects of N-acetyl Cysteine Supplementation Against Lead and Cadmium-Induced Brain Toxicity in Rat Models;Biological Trace Element Research;2021-11-24

4. Neuronal hyperactivity in a LRRK2-G2019S cellular model of Parkinson’s Disease;2021-06-23

5. Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases;Journal of Medicinal Chemistry;2021-01-22